Incremental prognostic value of stress/rest gated perfusion SPECT in patients with coronary artery disease -Subanalysis of the J-ACCESS study

Circulation Journal

Volumn 73, Issue 12, 2009, Pages 2288-2293

  Hashimoto, Akiyoshi ^a   Nakata, Tomoaki ^a,b   Wakabayashi, Takeru ^a   Kusuoka, Hideo ^c   Nishimura, Tsunehiko ^d  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hokkaido Prefectural Esashi Hospital   (Japan)

^c OSAKA NATIONAL HOSPITAL   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Japanese; Prognosis; Single photon emission computed tomography (SPECT)

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NITRATE; TETROFOSMIN TC 99M; WARFARIN;

AGED; ARTERY DISEASE; ARTICLE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GATED IMAGING; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART PERFUSION; HEART RATE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHARMACOLOGIC STRESS TESTING; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DATABASES AS TOPIC; DISEASE PROGRESSION; EXERCISE TEST; FEMALE; HEART FAILURE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 73349143308     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0212     Document Type: Article

References (33)

1. Nakajima K, Nishimura T. Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated SPECT with 99 mTc-tetrofosmin: A multicentre study involving 106 hospitals. Eur J Nucl Med Mol Imaging 2006; 33: 127-133.
2. Kusuoka H, Nishimura S, Yamashina A, Nakajima K, Nishimura T. Surveillance study for creating the national clinical database related to ECG-gated myocardial perfusion SPECT of ischemic heart disease: J-ACCESS study design. Ann Nucl Med 2006; 20: 195-202.
3. Nakajima K, Kusuoka H, Nishimura S, Yamashina A, Nishimura T. Normal limits of ejection fraction and volumes determined by gated SPECT in clinically normal patients without cardiac events: A study based on the J-ACCESS database. Eur J Nucl Med Mol Imaging 2007; 34: 1088-1096.
4. Nishimura T, Nakajima K, Kusuoka H, Yamashina A, Nishimura S. Prognostic study of risk stratification among Japanese patients with ischemic heart disease using gated myocardial perfusion SPECT: J-ACCESS study. Eur J Nucl Med Mol Imaging 2008; 35: 319-328.
5. Shinro M, Nakajima K, Horie M, Nakae I, Nishimura T. Prognostic value of normal stress myocardial perfusion imaging in Japanese population: A study based on the J-ACCESS Study. Circ J 2008; 72: 611-617.
6. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, et al. Effect of captopril on mortality in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival And Ventricular Enlargement (SAVE) trial. N Engl J Med 1992; 327: 669-677.
7. Aronow WS, Ahn C. Risk factors for new coronary events in a large cohort of very elderly patients with and without coronary artery disease. Am J Cardiol 1996; 77: 864-866.
8. Huikuri HV, Tapanainen JM, Lindgren K, Raatikainen P, Mäkikallio TH, Airaksinen KEJ, et al. Prediction of sudden cardiac death after myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2003; 42: 652-658.
9. Yasue H, Ogawa H, Tanaka H, Miyazaki S, Hattori R, Saito M, et al. Japanese antiplatelets myocardial infarction study (JAMIS) investigators: Effects of aspirin and trapidil ion cardiovascular events after acute myocardial infarction. Am J Cardiol 1999; 83: 1308-1313.
10. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: Executive summary: A report of the ACC/AA task force on practice guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients with Acute Myocardial Infarction). Circulation 2004; 110: 588-636.
11. Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, et al. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese acute myocardial infarction prospective (JAMP) study. Am Heart J 2004; 148: e8.
12. The Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-1676.
13. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al, J-LIT study group. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia: Primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002; 66: 1087-1095.
14. Berman DS, Abidov A, Kang X, Hayes SW, Friedman JD, Sciammarella MG, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004; 11: 414-423.
15. Pollock SG, Abbott RD, Boucher CA, Beller AG, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: Validation of models based on these tests. Circulation 1992; 85: 237-248.
16. Verschuren WM, Jacobs DR, Bloemberg BP, Kromhout D, Menotti A, Aravanis C, et al. Serum total cholesterol and long-term coronary heart disease mortality in different cultures: Twenty-five-year follow-up of the seven countries study. JAMA 1995; 274: 131-136.
17. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Ethnicity and long-term outcome after an acute coronary event: Multicenter myocardial ischemia research group. Am Heart J 1999; 138: 500-506.
18. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003; 108: 1404-1418.
19. Palmas W, Friedman JD, Diamond GA, Silber H, Kiat H, Berman DS, et al. Incremental prognostic value of simultaneous assessment of myocardial function and perfusion with technetium-99 m sestamibi for prediction of extent of coronary artery disease. J Am Coll Cardiol 1995; 25: 1024-1031.
20. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion singlephoton emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
21. Kawano H, Soejima H, Kojima S, Kitagawa A, Ogawa H. Sex differences of risk factors for acute myocardial infarction in Japanese patients. Circ J 2006; 70: 513-517.
22. Tamaki N. Guidelines for clinical use of cardiac nuclear medicine (JCS 2005). Circ J 2005; 69(Suppl IV): 1125-1202.
23. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
24. Hamer AW, Takayama M, Abraham KA, Roche AH, Kerr AR, Williams BF, et al. End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation 1994; 90: 2899-2904.
25. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 1999; 100: 1035-1042.
26. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: Risk stratification by the amount of stress-induced ischemia and the post stress ejection fraction. J Nucl Med 2001; 42: 831-837.
27. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362: 777-781.
28. Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, et al; Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 2005; 112: 3738-3744.
29. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
30. Ikeda T, Yoshino H, Sugi K, Tanno K, Shimizu H, Watanabe J, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: Results of a collaborative cohort study. J Am Coll Cardiol 2006; 48: 2268-2274.
31. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, et al, Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007; 116: 1482-1487.
32. Matsumoto N, Sato Y, Suzuki Y, Kunimasa T, Yoda S, Iida J, et al. Prognostic value of myocardial perfusion single-photon emission computed tomography for the prediction of future cardiac events in Japanese population: A middle-term follow-up study. Circ J 2007; 71: 1580-1585.
33. Nagao T, Chikamori T, Hida S, Igarashi Y, Kuwabara Y, Nishimura S, et al, Q-PROVE Study Group. Quantitative gated single-photon emission computed tomography with (99 m)Tc sestamibi predicts major cardiac events in elderly patients with known or suspected coronary artery disease: The QGS-Prognostic Value in the Elderly (Q-PROVE) Study. Circ J 2007; 71: 1029-1034.